Lucid Diagnostics Inc. (NASDAQ:LUCD) Q4 2024 Earnings Call Transcript
Operator: Good morning, and welcome to the Lucid Diagnostics Fourth Quarter 2024 Business Update Conference Call. At this time, all lines are in listen-only mode.
Lucid Diagnostics Inc. (LUCD)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Masters Capital Management Mike Masters | 2,727,273 | $4,063,637 | 0.2% | |
| 2. | Alyeska Investment Group Anand Parekh | 1,887,843 | $2,812,886 | 0.01% | |
| 3. | Renaissance Technologies Jim Simons | 459,065 | $684,007 | 0% | |
| 4. | Luminus Management Jonathan Barrett And Paul Segal | 456,644 | $680,400 | -56% | 0.22% |
| 5. | Ghisallo Capital Management Michael Germino | 422,004 | $628,786 | 0.05% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.32 | 33,218 | $43,794.61 | 565,443 | 2025-05-22 | Filing | |
| $1.32 | 129,684 | $171,520.06 | 532,225 | 2025-05-21 | Filing | |
| $1.30 | 187,098 | $242,291.91 | 402,541 | 2025-05-20 | Filing | |
| $1.32 | 33,218 | $43,794.61 | 350,000 | 2025-05-22 | Filing | |
| $1.32 | 129,684 | $171,520.06 | 316,782 | 2025-05-21 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.45 | 9,747 | $14,133.15 | 101,592 | 2023-09-26 | Filing | |
| $1.43 | 10,000 | $14,300.00 | 111,339 | 2023-09-26 | Filing | |
| $1.47 | 10,000 | $14,740.00 | 121,339 | 2023-09-26 | Filing | |
| $1.43 | 200 | $286.00 | 131,339 | 2023-09-25 | Filing | |
| $1.44 | 100 | $144.00 | 131,539 | 2023-09-21 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 888,874 | $1,324,422 | 0% | |
| 2. | 383,999 | $572,159 | 0.05% | |
| 3. | 383,082 | $570,792 | 0% | |
| 4. | 303,175 | $451,774 | 0% | |
| 5. | 190,455 | $283,778 | 0% |
News See All
Lucid Diagnostics Inc. (NASDAQ:LUCD) Q3 2024 Earnings Call Transcript
Operator: Good morning, and welcome to the Lucid Diagnostics Third Quarter 2024 Business Update Conference Call. At this time, all lines are in a listen-only mode.
Lucid Diagnostics Inc. (NASDAQ:LUCD) Q2 2024 Earnings Call Transcript
Operator: Good morning, and welcome to the Lucid Diagnostics Second Quarter 2024 Business Update Conference Call. At this time, all lines are in a listen-only mode.
Lucid Diagnostics Inc. (NASDAQ:LUCD) Q1 2024 Earnings Call Transcript
Operator: Good morning, and welcome to the Lucid Diagnostics First Quarter 2024 Business Update Conference Call. At this time all lines are in listen only mode.
Lucid Diagnostics Inc. (NASDAQ:LUCD) Q4 2023 Earnings Call Transcript
Operator: Good morning, and welcome to the Lucid Diagnostics Fourth Quarter and Full Year 2023 Business Update Conference Call. [Operator Instructions] Please note this event is being recorded.
Lucid Diagnostics Inc. (NASDAQ:LUCD) Q3 2023 Earnings Call Transcript
Operator: Good morning, and welcome to the Lucid Diagnostics Third Quarter 2023 Business Update Conference Call. All participants will be in a listen-only mode.
Lucid Diagnostics Inc. (NASDAQ:LUCD) Q2 2023 Earnings Call Transcript
Operator: Good day, and welcome to the Lucid Diagnostics Second Quarter 2023 Business Update Conference Call. [Operator Instructions] Please note, this event is being recorded.
Lucid Diagnostics Inc. (NASDAQ:LUCD) Q1 2023 Earnings Call Transcript
Operator: Welcome to the Lucid Diagnostics Business Update and First Quarter 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
Lucid Diagnostics Inc. (NASDAQ:LUCD) Q4 2022 Earnings Call Transcript
Operator: Welcome to the Lucid Diagnostics Business Update and Fourth Quarter 2022 Financial Results Conference Call. At this time, all participants will be in a listen-only mode.